Hung-Jui Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hung-Jui Tan has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Matthew E. Nielsen
Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
6 shared publicationsAngela B. Smith
Department of Urology
4 shared publicationsEthan Basch
Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina
4 shared publications- Jeannette T. Bensen
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
4 shared publications - Laura Farnan
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
4 shared publications Maihan B. Vu
Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, USA
4 shared publications
Latest Publications
- 6 November 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
Patient-Provider Communication, Treatment, and Survival in a Population-Based Cohort: The North Carolina-Louisiana Prostate Cancer Project
Purpose: Patient-provider communication (PPC) may be associated with receipt of definitive prostate cancer treatment and long-term outcomes. We examined these associations in a racially and geographically diverse population-based cohort. Methods: We analyzed data for 2,258 Black and White participants enrolled in the North Carolina-Louisiana Prostate Cancer Project (2004-2009), with longitudinal vital status follow-up through 2020. PPC was measured using three subscales: contextual knowledge, communication content, and interpersonal treatment. We evaluated associations between PPC and receipt of definitive treatment and clinical outcomes. Results: Communication content emerged as the most consistent PPC domain associated with clinical outcomes. Per five-point increase in communication content, the odds of receiving definitive treatment were higher for radiation therapy (odds ratio [OR], 1.49 [95% CI, 1.15 to 1.94]) and radical prostatectomy (OR, 1.73 [95% CI, 1.39 to 2.14]) compared with nondefinitive treatment. Communication content was also associated with greater likelihood of surgery within 3 months among prostatectomy recipients (OR, 1.66 [95% CI, 1.29 to 2.13]), with a directionally similar but nonsignificant association for radiation therapy. In competing-risk models, higher communication content was associated with lower prostate cancer–specific mortality (PCSM; subdistribution hazard ratio [sHR], 0.78 [95% CI, 0.61 to 0.99]). Associations varied by race and rurality, but formal interaction tests did not indicate effect measure modification. Conclusion: We found that higher communication content scores were associated with higher receipt of definitive treatment, shorter time to surgery, and lower PCSM. These findings highlight communication as a potentially modifiable component of the patient-provider encounter. Communication based on high informational quality is associated with long-term prostate cancer outcomes and represents a candidate target for future intervention research to improve prostate cancer care delivery.
- 6 November 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
Patient-Provider Communication, Treatment, and Survival in a Population-Based Cohort: The North Carolina-Louisiana Prostate Cancer Project
Purpose: Patient-provider communication (PPC) may be associated with receipt of definitive prostate cancer treatment and long-term outcomes. We examined these associations in a racially and geographically diverse population-based cohort. Methods: We analyzed data for 2,258 Black and White participants enrolled in the North Carolina-Louisiana Prostate Cancer Project (2004-2009), with longitudinal vital status follow-up through 2020. PPC was measured using three subscales: contextual knowledge, communication content, and interpersonal treatment. We evaluated associations between PPC and receipt of definitive treatment and clinical outcomes. Results: Communication content emerged as the most consistent PPC domain associated with clinical outcomes. Per five-point increase in communication content, the odds of receiving definitive treatment were higher for radiation therapy (odds ratio [OR], 1.49 [95% CI, 1.15 to 1.94]) and radical prostatectomy (OR, 1.73 [95% CI, 1.39 to 2.14]) compared with nondefinitive treatment. Communication content was also associated with greater likelihood of surgery within 3 months among prostatectomy recipients (OR, 1.66 [95% CI, 1.29 to 2.13]), with a directionally similar but nonsignificant association for radiation therapy. In competing-risk models, higher communication content was associated with lower prostate cancer–specific mortality (PCSM; subdistribution hazard ratio [sHR], 0.78 [95% CI, 0.61 to 0.99]). Associations varied by race and rurality, but formal interaction tests did not indicate effect measure modification. Conclusion: We found that higher communication content scores were associated with higher receipt of definitive treatment, shorter time to surgery, and lower PCSM. These findings highlight communication as a potentially modifiable component of the patient-provider encounter. Communication based on high informational quality is associated with long-term prostate cancer outcomes and represents a candidate target for future intervention research to improve prostate cancer care delivery.
- Open Access
- 10 August 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e74150
Building a Natural Language Processing Augmented Information Support System to Enhance Supportive Care for Patients With Prostate Cancer and Families: User-Centered, Iterative Approach
Background: Patients with prostate cancer and their families face significant challenges during transitions from diagnosis to treatment and posttreatment self-management, particularly in accessing, understanding, and using complex health information. Objective: We aimed to develop the Interactive Prostate Cancer Information, Communication, and Support Program (iPICS), a natural language processing (NLP)–augmented eHealth platform designed to enhance care continuity, support decision-making, and improve health outcomes for patients and families. Methods: This study used an iterative, user-centered design approach to design, develop, and refine iPICS, guided by responsible AI principles. The iterative development process advanced from an initial needs assessment through iterative formative and summative prototype evaluations, culminating in a final evaluation of field deployment readiness via semistructured interviews and focus groups with patients with prostate cancer and family members from diverse sociodemographic backgrounds. Thematic analysis was conducted to identify critical functionalities and content, using double coding and team-based consensus procedures. Participants’ feedback was integrated during the platform’s refinement to ensure iPICS’ usability, accessibility, security, and functionality. Results: A total of 18 patients with prostate cancer and 7 family members participated in 2 semistructured interviews and 17 focus groups. Most participants were older adults and had at least a high school education. Participants identified 5 major themes relevant to iPICS development: functional requirements, user interface design recommendations, content and visualization needs, program delivery preferences, and privacy and data security concerns. These themes informed the iPICS prototype design, development, and refinement, which include 3 core components: Inform, a multimedia health information resource hub; Dialog, an NLP-augmented consultation recording summarization tool for patient-provider communication; and Snap, a moderated online peer-support forum. Key features of iPICS include: Inform is an evidence-based, guideline-informed multimedia health information paired with National Institutes of Health–sponsored MedlinePlus papers; Dialog is an NLP-powered recording with keyword extraction and hyperlinking; and Snap is peer-support functionalities moderated by nurses to ensure safety and reliability. iPICS development was also compliant with HIPAA (Health Insurance Portability and Accountability Act) standards and aligned with user needs while ensuring usability throughout deployment. Conclusions: The NLP-augmented iPICS was developed using an iterative user-centered design approach to support patients with prostate cancer and their families. It offers a scalable solution for ethical, transparent, and inclusive supportive survivorship care, particularly during critical care transitions. As a formative qualitative study with a small sample, this phase did not evaluate patient- or family-reported outcomes. Our ongoing studies will evaluate the effects of iPICS on patient- and family-reported outcomes and explore adaptation to other cancers and chronic conditions.
- 10 August 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e74150
Open AccessBuilding a Natural Language Processing Augmented Information Support System to Enhance Supportive Care for Patients With Prostate Cancer and Families: User-Centered, Iterative Approach
Background: Patients with prostate cancer and their families face significant challenges during transitions from diagnosis to treatment and posttreatment self-management, particularly in accessing, understanding, and using complex health information. Objective: We aimed to develop the Interactive Prostate Cancer Information, Communication, and Support Program (iPICS), a natural language processing (NLP)–augmented eHealth platform designed to enhance care continuity, support decision-making, and improve health outcomes for patients and families. Methods: This study used an iterative, user-centered design approach to design, develop, and refine iPICS, guided by responsible AI principles. The iterative development process advanced from an initial needs assessment through iterative formative and summative prototype evaluations, culminating in a final evaluation of field deployment readiness via semistructured interviews and focus groups with patients with prostate cancer and family members from diverse sociodemographic backgrounds. Thematic analysis was conducted to identify critical functionalities and content, using double coding and team-based consensus procedures. Participants’ feedback was integrated during the platform’s refinement to ensure iPICS’ usability, accessibility, security, and functionality. Results: A total of 18 patients with prostate cancer and 7 family members participated in 2 semistructured interviews and 17 focus groups. Most participants were older adults and had at least a high school education. Participants identified 5 major themes relevant to iPICS development: functional requirements, user interface design recommendations, content and visualization needs, program delivery preferences, and privacy and data security concerns. These themes informed the iPICS prototype design, development, and refinement, which include 3 core components: Inform, a multimedia health information resource hub; Dialog, an NLP-augmented consultation recording summarization tool for patient-provider communication; and Snap, a moderated online peer-support forum. Key features of iPICS include: Inform is an evidence-based, guideline-informed multimedia health information paired with National Institutes of Health–sponsored MedlinePlus papers; Dialog is an NLP-powered recording with keyword extraction and hyperlinking; and Snap is peer-support functionalities moderated by nurses to ensure safety and reliability. iPICS development was also compliant with HIPAA (Health Insurance Portability and Accountability Act) standards and aligned with user needs while ensuring usability throughout deployment. Conclusions: The NLP-augmented iPICS was developed using an iterative user-centered design approach to support patients with prostate cancer and their families. It offers a scalable solution for ethical, transparent, and inclusive supportive survivorship care, particularly during critical care transitions. As a formative qualitative study with a small sample, this phase did not evaluate patient- or family-reported outcomes. Our ongoing studies will evaluate the effects of iPICS on patient- and family-reported outcomes and explore adaptation to other cancers and chronic conditions.
- 7 August 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (9) , 832
Online support needs and preferences for survivors of testicular cancer: a qualitative descriptive study
- 7 August 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (9) , 832
Online support needs and preferences for survivors of testicular cancer: a qualitative descriptive study
- 15 September 2025
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 23 (6) , 102435
Data Sources for Clinical T1 Renal Masses and the Potential for Bias
- 15 September 2025
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 23 (6) , 102435
Data Sources for Clinical T1 Renal Masses and the Potential for Bias
- 1 July 2025
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 12 (4) , 459-468
Use and Usefulness of Risk Prediction Tools in Urologic Surgery: Current State and Path Forward
While the enthusiasm for artificial intelligence (AI) to enhance surgical decision-making continues to grow, the preceding advance of risk prediction tools (RPTs) has had limited impact to date. To help inform the development of AI-powered tools, we evaluated the role of RPTs and prevailing attitudes among urologists. We conducted a national mixed methods study using a sequential explanatory design. Through the 2019 AUA Census, we surveyed urologists on RPT use, helpfulness, and trust. Based on responses, we interviewed 25 participants on RPTs, risk evaluation, and surgical decision-making. Coding-based thematic analysis was applied and integrated with survey findings. Among 2,081 urologic surgeons (weighted sample 12,366), 30.4% (95% CI 28.2-32.6%) routinely used RPTs and 34.3% (95% CI 31.9-36.6%) found them helpful while 47.0% (95% CI 44.6-49.5%) generally trusted their own assessment over RPT-generated estimates. More years in practice was negatively associated with RPT use, helpfulness, and trust (p<0.001). Qualitatively, participants described relying on their intuition for surgical risks and benefit and employing gist-based approximations rather than numerical information, which RPTs provide. RPT helpfulness centered on risk/benefit confirmation, calibration, and communication, but methodological (e.g., individual vs. group estimates, missing variables) and operational (e.g., ease of use, clinical workflow) challenges limit greater RPT use. Despite their wide availability, RPTs remain limited in their use and helpfulness. This reflects both the intuitive nature of surgical decision-making and implementation challenges. For AI to reach its promise and improve surgical care and outcomes, both types of barriers will need to be addressed.
- 1 July 2025
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 12 (4) , 459-468
Use and Usefulness of Risk Prediction Tools in Urologic Surgery: Current State and Path Forward
While the enthusiasm for artificial intelligence (AI) to enhance surgical decision-making continues to grow, the preceding advance of risk prediction tools (RPTs) has had limited impact to date. To help inform the development of AI-powered tools, we evaluated the role of RPTs and prevailing attitudes among urologists. We conducted a national mixed methods study using a sequential explanatory design. Through the 2019 AUA Census, we surveyed urologists on RPT use, helpfulness, and trust. Based on responses, we interviewed 25 participants on RPTs, risk evaluation, and surgical decision-making. Coding-based thematic analysis was applied and integrated with survey findings. Among 2,081 urologic surgeons (weighted sample 12,366), 30.4% (95% CI 28.2-32.6%) routinely used RPTs and 34.3% (95% CI 31.9-36.6%) found them helpful while 47.0% (95% CI 44.6-49.5%) generally trusted their own assessment over RPT-generated estimates. More years in practice was negatively associated with RPT use, helpfulness, and trust (p<0.001). Qualitatively, participants described relying on their intuition for surgical risks and benefit and employing gist-based approximations rather than numerical information, which RPTs provide. RPT helpfulness centered on risk/benefit confirmation, calibration, and communication, but methodological (e.g., individual vs. group estimates, missing variables) and operational (e.g., ease of use, clinical workflow) challenges limit greater RPT use. Despite their wide availability, RPTs remain limited in their use and helpfulness. This reflects both the intuitive nature of surgical decision-making and implementation challenges. For AI to reach its promise and improve surgical care and outcomes, both types of barriers will need to be addressed.
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research
Supplemental Table 1. UNC Cancer Survivorship Cohort cancer-specific questionnaires
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research
Supplemental Table 1. UNC Cancer Survivorship Cohort cancer-specific questionnaires
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Data from The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research
Background:Rapid growth in the number of US cancer survivors drives the need for ongoing research efforts to improve outcomes and experiences after cancer. In this study, we describe the University of North Carolina (UNC) Cancer Survivorship Cohort, a medical center–based cohort of adults with cancer that integrates medical record–abstracted cancer information, patient-reported outcomes, and biological specimens.Methods:Participants ages 18+ were recruited from UNC oncology clinics between April 2010 and August 2016. After enrollment, participants completed questionnaires on a range of topics including demographics, health history, healthcare access and utilization, quality of life, and symptoms. Blood samples and tumor tissue specimens were collected and processed by study staff, and cancer characteristics and other clinical data were abstracted from electronic medical records. Participants consented to recontact for future studies and linkage of their data with other data resources.Results:In total, 3,999 participants with a cancer diagnosis were enrolled in the cohort. The most common cancer types among those enrolled included breast (N = 866), uterine (N = 458), colorectal (N = 300), prostate (N = 296), and head and neck (N = 248) cancers. Blood specimens were collected for 3,027 participants (76%). Additional participants without cancer (N = 1,299) were also enrolled, and the majority (62%) provided biospecimen samples.Conclusions:We encourage a wide collaboration with investigators across institutions seeking to advance research in cancer survivorship. Procedures are in place to support proposals for use of existing or linked data and for proposals that require participant recontact or analysis of biospecimens.Impact:The UNC Cancer Survivorship Cohort is a unique resource for cancer survivorship research.
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research
Background:Rapid growth in the number of US cancer survivors drives the need for ongoing research efforts to improve outcomes and experiences after cancer. In this study, we describe the University of North Carolina (UNC) Cancer Survivorship Cohort, a medical center–based cohort of adults with cancer that integrates medical record–abstracted cancer information, patient-reported outcomes, and biological specimens.Methods:Participants ages 18+ were recruited from UNC oncology clinics between April 2010 and August 2016. After enrollment, participants completed questionnaires on a range of topics including demographics, health history, healthcare access and utilization, quality of life, and symptoms. Blood samples and tumor tissue specimens were collected and processed by study staff, and cancer characteristics and other clinical data were abstracted from electronic medical records. Participants consented to recontact for future studies and linkage of their data with other data resources.Results:In total, 3,999 participants with a cancer diagnosis were enrolled in the cohort. The most common cancer types among those enrolled included breast (N = 866), uterine (N = 458), colorectal (N = 300), prostate (N = 296), and head and neck (N = 248) cancers. Blood specimens were collected for 3,027 participants (76%). Additional participants without cancer (N = 1,299) were also enrolled, and the majority (62%) provided biospecimen samples.Conclusions:We encourage a wide collaboration with investigators across institutions seeking to advance research in cancer survivorship. Procedures are in place to support proposals for use of existing or linked data and for proposals that require participant recontact or analysis of biospecimens.Impact:The UNC Cancer Survivorship Cohort is a unique resource for cancer survivorship research.
- 6 September 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (12) , 1556-1563
The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research
Background: Rapid growth in the number of US cancer survivors drives the need for ongoing research efforts to improve outcomes and experiences after cancer. In this study, we describe the University of North Carolina (UNC) Cancer Survivorship Cohort, a medical center–based cohort of adults with cancer that integrates medical record–abstracted cancer information, patient-reported outcomes, and biological specimens. Methods: Participants ages 18+ were recruited from UNC oncology clinics between April 2010 and August 2016. After enrollment, participants completed questionnaires on a range of topics including demographics, health history, healthcare access and utilization, quality of life, and symptoms. Blood samples and tumor tissue specimens were collected and processed by study staff, and cancer characteristics and other clinical data were abstracted from electronic medical records. Participants consented to recontact for future studies and linkage of their data with other data resources. Results: In total, 3,999 participants with a cancer diagnosis were enrolled in the cohort. The most common cancer types among those enrolled included breast (N = 866), uterine (N = 458), colorectal (N = 300), prostate (N = 296), and head and neck (N = 248) cancers. Blood specimens were collected for 3,027 participants (76%). Additional participants without cancer (N = 1,299) were also enrolled, and the majority (62%) provided biospecimen samples. Conclusions: We encourage a wide collaboration with investigators across institutions seeking to advance research in cancer survivorship. Procedures are in place to support proposals for use of existing or linked data and for proposals that require participant recontact or analysis of biospecimens. Impact: The UNC Cancer Survivorship Cohort is a unique resource for cancer survivorship research.
- 6 September 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (12) , 1556-1563
The University of North Carolina Cancer Survivorship Cohort: A Resource for Collaborative Survivorship Research
Background: Rapid growth in the number of US cancer survivors drives the need for ongoing research efforts to improve outcomes and experiences after cancer. In this study, we describe the University of North Carolina (UNC) Cancer Survivorship Cohort, a medical center–based cohort of adults with cancer that integrates medical record–abstracted cancer information, patient-reported outcomes, and biological specimens. Methods: Participants ages 18+ were recruited from UNC oncology clinics between April 2010 and August 2016. After enrollment, participants completed questionnaires on a range of topics including demographics, health history, healthcare access and utilization, quality of life, and symptoms. Blood samples and tumor tissue specimens were collected and processed by study staff, and cancer characteristics and other clinical data were abstracted from electronic medical records. Participants consented to recontact for future studies and linkage of their data with other data resources. Results: In total, 3,999 participants with a cancer diagnosis were enrolled in the cohort. The most common cancer types among those enrolled included breast (N = 866), uterine (N = 458), colorectal (N = 300), prostate (N = 296), and head and neck (N = 248) cancers. Blood specimens were collected for 3,027 participants (76%). Additional participants without cancer (N = 1,299) were also enrolled, and the majority (62%) provided biospecimen samples. Conclusions: We encourage a wide collaboration with investigators across institutions seeking to advance research in cancer survivorship. Procedures are in place to support proposals for use of existing or linked data and for proposals that require participant recontact or analysis of biospecimens. Impact: The UNC Cancer Survivorship Cohort is a unique resource for cancer survivorship research.
- 1 February 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 211 (2) , 266-275
Feasibility, Acceptability, and Outcomes of a Mobile Health Tool for Radical Cystectomy Recovery
Postoperative education and symptom tracking are essential following cystectomy to reduce readmission rates and information overload. To address these issues, an internet-based tool was developed to provide education, alerts, and symptom tracking. We aimed to evaluate the tool's feasibility, acceptability, and impact on complication and readmission rates. 33 eligible patients over 18 years old scheduled for cystectomy were enrolled. Patients were asked to use the mHealth tool daily for the first 2 weeks, then less frequently up to 90 days after discharge. Descriptive statistics were used to summarize study variables. Feasibility was defined as at least 50% of patients using the tool once a week, and acceptability as patient satisfaction of >75%. Use of the mHealth tool was feasible, with 90% of patients using it 1 week after discharge, but engagement declined over time to 50%, with technological difficulties being the main reason for non-engagement. Patient and provider acceptability was high, with satisfaction >90%. Within 90 days, 36% experienced complications after discharge, and 30% were readmitted. Engagement with the mHealth application varied but was not statistically associated with readmission (P = .21). The study showed that the electronic mobile health intervention for patients undergoing cystectomy was feasible, acceptable, and provided valuable educational content and symptom management. Future larger studies are needed to determine the tool's effectiveness in improving patient outcomes and its potential implementation into routine clinical care.
- 1 February 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 211 (2) , 266-275
Feasibility, Acceptability, and Outcomes of a Mobile Health Tool for Radical Cystectomy Recovery
Postoperative education and symptom tracking are essential following cystectomy to reduce readmission rates and information overload. To address these issues, an internet-based tool was developed to provide education, alerts, and symptom tracking. We aimed to evaluate the tool's feasibility, acceptability, and impact on complication and readmission rates. 33 eligible patients over 18 years old scheduled for cystectomy were enrolled. Patients were asked to use the mHealth tool daily for the first 2 weeks, then less frequently up to 90 days after discharge. Descriptive statistics were used to summarize study variables. Feasibility was defined as at least 50% of patients using the tool once a week, and acceptability as patient satisfaction of >75%. Use of the mHealth tool was feasible, with 90% of patients using it 1 week after discharge, but engagement declined over time to 50%, with technological difficulties being the main reason for non-engagement. Patient and provider acceptability was high, with satisfaction >90%. Within 90 days, 36% experienced complications after discharge, and 30% were readmitted. Engagement with the mHealth application varied but was not statistically associated with readmission (P = .21). The study showed that the electronic mobile health intervention for patients undergoing cystectomy was feasible, acceptable, and provided valuable educational content and symptom management. Future larger studies are needed to determine the tool's effectiveness in improving patient outcomes and its potential implementation into routine clinical care.